Cholic acid is the endogenous 12α-hydroxylated bile acid, which possesses enhanced cholesterol absorption properties compared to its 12-desoxy counterpart, chenodeoxycholic acid. The oxysterol 12α-hydroxylase enzyme is cytochrome P450 8B1 (P450 8B1), which regioselectively and stereoselectively incorporates the 12α-hydroxy group in 7α-hydroxycholest-4-en-3-one, the biosynthetic precursor of cholic acid. Despite the vital role of P450 8B1 activity in cardiovascular health, research studies of other 12α-hydroxy steroid derivatives are rare. A synthetic route to incorporate a C12α-hydroxy group into the C12-methylene (-CH 2 -) in dehydroepiandrosterone derivatives is disclosed. The incorporation of the C12-oxygen was accomplished through a copper mediated Schönecker oxidation of an imino-pyridine intermediate, introducing the 12β-hydroxy group. The resulting 12β-hydroxy steroid derivative was oxidized to the C12-ketone, which was stereoselectively reduced with lithium tri-sec-butylborohydride to afford the 12α-hydroxy stereochemistry. The C7-position was oxidized to yield the various 7-keto, 7β-hydroxy, and 7α-hydroxy derivatives. Furthermore, 7-ketodehydroepiandrosterone and 12 α-hydroxy-7-ketodehydroepiandrosterone both displayed NMDA receptor antagonistic activities at 10 μM concentrations. These C12α-hydroxy steroids will be used as tools to identify new biochemical properties of the enzymatic products of P450 8B1, the oxysterol 12α-hydroxylase.
Introduction
Cytochrome P450 8B1 is the oxysterol 12 α-hydroxylase enzyme, which oxidizes 7α-hydroxy-cholest-4-en-3-one to form 7α-,12α-dihydroxycholest-4-en-3-one [1, 2] (Fig. 1A) , the biosynthetic precursor of cholic acid, the 12 α-hydroxylated bile acid (Fig. 1B) . Bile acids form micelles, which regulate the intestinal absorption of lipids [3] . In particular, cholic acid supplementation has been shown to enhance the absorption of cholesterol [4] . Moreover, mice lacking the CYP8B1 gene encoding for P450 8B1, showed a resistance to weight gain when fed a high-cholesterol diet [5] .
Furthermore, the isolation of other steroids with a 12α-hydroxy group has been reported. For instance, a 12α-hydroxypregnenolone derivative, named menarandroside A (Fig. 1C) , has been recently isolated from plants (Cynanchum marnierianum) [6] . This novel 12α-hydroxylated steroid was identified from a bio-guided fractionation assay that detected the stimulation of glucagon-like peptide 1 (GLP-1) secretion, suggesting anti-diabetic activity. Other 12α-hydroxylated sterol plant natural products have been previously isolated in plants [7] .
Moreover, although it is an endogenous steroid hormone, 7-ketodehydroepiandrosterone and its 3-acetate form have been used to treat certain health conditions. For example, 7-keto dehydroepiandrosterone-3-acetate (7-keto DHEA-3OAc) has been shown to reduce post-traumatic stress disorder (PTSD) symptoms [8] and also to reverse the resting metabolic rate associated with dieting [9] . 7-Keto DHEA has also decreased voluntary intake of ethanol in male rats [10] . The various 7-oxygenated DHEA forms (7β-hydroxy-, 7α-hydroxy, and 7-keto DHEA) are interconverted by liver 11β-hydroxysteroid dehydrogenase 1 [11] . In addition, 7-keto DHEA has been shown to be effective at enhancing weight loss [12] . Due to the steroid backbone of 7-keto DHEA, it is reasonable to hypothesize that P450 8B1 would recognize 7-keto DHEA as a substrate and incorporate a 12α-hydroxy group into 7-keto DHEA.
Access to 12α-hydroxylated steroid structures would be necessary to explore their biochemical properties and facilitate the identification of new bioactive 12α-hydroxy steroid products arising from P450 8B1 activity. However, there is no known report to introduce a 12α-hydroxy group from a C12-desoxy steroid. Therefore, a synthetic route to introduce a C12 α-hydroxy group from the methylene (-CH 2 -) in the steroid backbone was developed. This report focuses on the syntheses of 12 α-hydroxy dehydroepiandrosterone (Figs. 2, 1) and its 7-oxygenated derivatives (i.e. 7-keto-,7α-hydroxy-, and 7β-hydroxy) (Figs. 2, 2, 3, and 4) beginning with dehydroepiandrosterone (DHEA). We further tested the hypothesis that 7-ketodehydroepiandrosterone is an N-methyl-D-asparatate (NMDA) receptor antagonist and found that both 7-ketodehydroepiandrosterone and 12α-hydroxy-7-ketodehydroepiandrosterone (2) had antagonistic effects towards the NMDA receptor.
Synthesis of 12 α-Hydroxy dehydroepiandrosterone (1)
The incorporation of a 12β-hydroxy group from a DHEA-imine derivative through a copper mediated oxygenation has been reported [13] [14] [15] . For the synthesis of 12α-hydroxy DHEA (compound 1), dehydroepiandrosterone (DHEA, Scheme 1) was protected as the DHEA-3-O-tert-butyldimethylsilyl ether 5, which was converted to the pyridineimine derivative at C17 (Scheme 1, 6). The Schönecker protocol through a copper mediated oxidation resulted in the introduction of the 12β-hydroxy group to yield 12β-hydroxy DHEA-3-OTBDMS ether 7 [13] [14] [15] . The resulting C17-ketone would be protected as ketal 8. The C12 β-hydroxy group of ketal 8 was oxidized to the C12-ketone 9. Subsequent stereoselective reduction at the C12-position gave the 12α-hydroxy compound 10. Various reducing conditions were explored to find the optimal hydride reagent as summarized in Table 1 . In general, a sterically hindered hydride (i.e. lithium triethylborohydride and lithium tri-sec-butylborohydride) source gave the 12α-hydroxy epimer as the major diastereomer. Deprotection of the TBDMS group and the C17-ketal of intermediate 10 with dilute HCl (aqueous) in THF yielded 12 α-hydroxy DHEA (1) .
Stereoselective Reduction of the C12-Ketone (Compound 9) with Various Reducing Agents
Synthesis of 12 α-hydroxy-7-keto-dehydroepiandrosterone (2)
The synthesis of 12α-hydroxy-7-keto dehydroepiandrosterone (2) commenced with 12α-hydroxy DHEA (Scheme 2). The dihydroxy compound (1) was diacetylated with pyridine and acetic anhydride as the solvent (1:10, v/v) using experimental conditions previously employed [15] . The C7-position was oxidized to the C7-keto group using CrO 3 and 3,5-dimethylpyrazole in CH 2 Cl 2 (Scheme 2). The resulting diacetate (12) was deprotected with K 2 CO 3 in CH 3 OH to yield 12α-hydroxy-7-keto DHEA (2) (Fig. 3 : crystal structure of compound 2).
Synthesis of 7α-,12α-dihydroxy-dehydroepiandrosterone (3)
In order to efficiently access 7α-,12α-dihydroxy DHEA (3), we hypothesized that a 7-,12-diketo steroid intermediate (e.g. Scheme 3, 13) could be stereoselectively reduced by lithium tri-sec-butylborohydride (L-Selectride) to furnish the α-hydroxy stereochemistry at both the C7-and C12-positions. This stereoselective reduction of the diketone was based on the observation that L-Selectride results in the delivery of the hydride onto the β-face of C7-keto steroid backbones [16] and C12-keto backbones (vide supra, Scheme 1, 9 to 10).
The synthesis of the 7α-,12α-dihydroxy DHEA (3) commenced with the oxidation of the C7-allylic position of 12-keto C17-ketal 9 with CrO 3 to furnish diketone 13. Gratifyingly, diketone 13 was reduced with LSelectride to afford the 7α-,12α-dihydroxy ketal 14. Treating ketal 14 with dilute HCl in THF resulted in the deprotection of both the C17-ketal and the C3-tert-butyldimethylsilyl ether to afford 7α-,12α-dihydroxy DHEA (3) (Scheme 3) (Fig. 4 : crystal structure of compound 3).
1
H NMR, Supporting Information). This mixture was purified by silica gel column chromatography, giving the 7β-to 7α-epimeric mixture, which would be resolved over the subsequent five steps towards the final product, 4. The 7-hydroxy group of alcohol 17 was protected as the tert-butyldimethylsilyl diether 18 by refluxing with TBDMSCl and imidazole in CH 3 CN. The acetate was methanolyzed with K 2 CO 3 in CH 3 OH to yield alcohol 19. Alcohol 19 was oxidized with pyridinium chlorochromate (PCC) to yield C12-ketone 20, which was stereoselectively reduced with L-Selectride to give the 12α-hydroxy epimer 21. Deprotection of the two tert-butyldimethylsilyl groups and the C17-ketal with HCl in water and THF to furnish 7β-,12α-dihydroxy DHEA 4. Fig. 1 . Examples of naturally occurring 12 α-hydroxylated steroids: (A) 7 α-hydroxycholest-4-en-3-one, (B) cholic acid, and (C) menarandroside A. Fig. 2 . 12α-Hydroxy-dehydroepiandrosterone (1), 12α-hydroxy-7-keto-dehydroepiandrosterone (2), 7α-,12 α-dihydroxy-dehydroepiandrosterone (3), and 7β-,12α-dihydroxy-dehydroepiandrosterone (4) were synthesized from dehydroepiandrosterone (DHEA).
Synthesis of 12β-Hydroxy-Dehydroepiandrosterone (22)
12β-Hydroxydehydroepiandrosterone (22) was accessed through deprotection of the TBDMS group of Schoenecker product (compound 7) with HCl and CH 3 OH/CH 2 Cl 2 ( Fig. 5 : crystal structure of compound 22).
2.
1 H NMR analysis of C7-and C12-oxygenated steroid derivatives -diagnostic signals Intriguingly, when the C7-methylene position is converted to the C7-keto-Δ 5,6 -steroid scaffold, the Δ 5 -proton shifts downfield from δ 5.39 ppm (apparent doublet (J = 6 Hz) of compound 1, Fig. 6A ) to δ 5.75 ppm as a broad singlet (Fig. 6B, compound 2) . On the other hand, when the C7-position bears a C7α-hydroxy intermediate (compound 3) the Δ
5
-proton appears as a doublet (J = 6 Hz) at δ 5.67 ppm (Fig. 6C ). However, when the C7-hydroxy group is in the β-orientation (compound 4), the Δ
-proton has an upfield shift and appears as a singlet at δ 5.33 ppm (Fig. 6D) .
Furthermore, the C12-proton of the C12-oxygenated steroids had a diagnostic peak depending on whether the hydroxy group was in the 12β-or the 12α-orientation. For example, the C12α-proton (axial) of 12β-hydroxy DHEA (compound 22) had a chemical shift of δ 3.80 ppm, Scheme 1. Synthesis of 12 α-hydroxy DHEA (1) from DHEA. The ratios of the 12β-hydroxy and 12α-hydroxy products were determined by integration of the C18-methyl peak of the 1 H NMR spectra of the crude reaction material (δ 0.86 ppm for the 12α-hydroxy epimer, and δ 0.92 ppm for the 12β-hydroxy epimer). b THF (5 ml) was the solvent, the reaction was run at −78°C with 30 mg of starting material (Compound 9). c CH 3 OH (5 ml) was the solvent, the reaction was run at 0°C with 30 mg of starting material (Compound 9).
Scheme 2. Synthesis of 12α-hydroxy-7-keto-dehydroepiandrosterone (2) from 12α-hydroxy DHEA (1). Fig. 3 . Crystal structure of 12α-hydroxy-7-keto DHEA (compound 2).
S.D. Offei et al.
Steroids 140 (2018) [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] which appeared as a doublet of doublets (J = 11 and 4.6 Hz) (Fig. 6E ).
In contrast, the C12β-proton (equatorial) of 12α-hydroxy DHEA (compound 1) appeared as a broad singlet at δ 4.14 ppm.
2.1. Effect of 7-Ketodehydroepiandrosterone and 12α-Hydroxy-7-ketodehydroepiandrosterone on the NMDA receptor 7-Ketodehydroepiandrosterone has been shown to reduce symptoms of post-traumatic stress disorder (PTSD) [8] . Therefore, we hypothesized that this compound can act as an N-methyl-D-aspartate (NMDA) receptor antagonist, which has been the activity associated with ketamine, another compound used to treat PTSD [17] . Furthermore, with access to the 12α-hydroxylated derivative (12α-hydroxy-7-ketodehydroepiandrosterone, compound 3), the effect of the 12α-hydroxy group in the steroid scaffold was tested. Interestingly, both compounds were found to have antagonistic activity towards the NMDA receptor at 10 μM concentration (Fig. 7) . Other steroid derivatives have shown biological activity towards the NMDA receptor [18, 19] , confirming steroids as potential ligands to modulate NMDA receptor activity.
Conclusion
In summary, a synthetic route to introduce a 12α-hydroxy group from the C12-methylene in steroid derivatives was established. The key S.D. Offei et al. Steroids 140 (2018) [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] feature of this route involved three transformations: (1) the coppermediated Schönecker oxidation to introduce the 12β-hydroxy group, (2) oxidation of the 12β-hydroxy to the C12-keto moiety, and (3) stereoselective reduction to the 12α-hydroxy group using lithium tri-secbutylborohydride (i.e. L-Selectride). Both 7-ketodehydroepiandrosterone and 12α-hydroxy-7-ketodehydroepiandrosterone (3) were found to have NMDA receptor antagonist properties at 10 μM concentrations. These novel 12α-hydroxy steroids and sterols will be used as chemical tools to explore the biochemistry of cytochrome P450 8B1, the oxysterol 12α-hydroxylase enzyme implicated in cardiovascular health.
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Experimental section
Materials. Reagents and solvents were purchased from commercial sources. TLC plates (silica gel) with 254 nm fluorescent indicator (Sigma, St. Louis, MO) were used to monitor reactions. Both a UV lamp and ceric ammonium molybdate staining were used to visualize compounds on TLC. Silica gel (Silicycle (Quebec, Canada), 40-63 μm, 60 Å) was used for flash column separations. A WXG-4 optical polarimeter (Bante Instruments, Ltd, Shanghai, China) was used to measure optical rotations with a 10 cm long cell. A melting point apparatus (Global Medical and Lab Solutions, India) was used to measure the melting points of each compound. A Bruker 500 Advance III High Definition (HD) NMR spectrometer (Billerica, MA) was used to record the spectra of synthesized intermediates at 500 MHz for 
X-Ray crystallaography
Single crystals of C 38 H 58 O 9 (7α-,12α-dihydroxy DHEA, compound 3) and C 19 H 30 O 6 (12α-hydroxy-7-keto DHEA, compound 2) were prepared by slow evaporation of 1:1 mixture of methanol and dichloromethane. Suitable colorless plate-like crystals for compounds 3 and 2, with dimensions of 0.33 mm × 0.30 mm × 0.03 mm and 0.33 mm × 0.27 mm × 0.13 mm, were mounted in paratone oil onto a nylon loop. Single crystals of C 19 H 28 O 3 (12β-hydroxy DHEA, compound 22) were prepared by slow evaporation of a 1:1 mixture of diethyl ether and acetone. A suitable colorless plank-like crystal for compound 22 with dimensions of 0.50 mm × 0.20 mm × 0.10 mm, was mounted in paratone oil onto a nylon loop. All data were collected at 98(2) K, using a Rigaku AFC12/Saturn 724 CCD fitted with MoKα radiation (λ = 0.71075 Å). Data collection and unit cell refinement were performed using CrysAlisPro software [20] . The total number of data were measured in the range 4.7°< 2θ < 52.0°, 4.7°< 2θ < 52.0°and 5.0°< 2θ < 51.0°for compounds 3, 2, and 22, respectively, using ω scans. Data processing and absorption correction, giving minimum and maximum transmission factors (0.9144, 1.000 for compound 3, 0.8617, 1.000 for compound 2, 0.8958, 1.000 for compound 22) were accomplished with CrysAlisPro [20] and SCALE3 ABSPACK [21] , respectively. The structure, using Olex2 [22] , was solved with the ShelXT [23] structure solution program using direct methods and refined (on F 2 ) with the ShelXL [22] refinement package using full-matrix, leastsquares techniques. All non-hydrogen atoms were refined with anisotropic displacement parameters. All carbon bound hydrogen atom positions were determined by geometry and refined by a riding model. All oxygen bound hydrogen atom positions, on compound 3, were determined by electron density plots, except for H6 hydrogen atom which was placed on a calculated position. All solvent bound hydrogen atom positions, on compound 2, were determined by electron density plots. Non-solvent oxygen bound hydrogen atom positions were determined by geometry and refined by a riding model, except for hydrogen atom, H4A, which was determined by electron density plot. All oxygen bound hydrogen atom positions, on compound 22, were determined by electron density plots. Crystal structures were submitted to the Cambridge Structural Database (CSD) with CSD numbers: 1870940, 1870939, and 1,870,941 for compounds 2, 3, and 22.
Brain slice preparation and electrophysiology
Male and female C57BL/6J mice were used. All procedures were approved by the University of Texas at San Antonio Institutional Animal care and Use Committees in accordance with the National Institutes of Health guidelines. Mice were deeply anesthetized with isoflurane followed by rapid decapitation. The brain was quickly removed and chilled in ice cold cutting solution containing (in mM): 110 cholineCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 7 MgCl 2 , 0.5 CaCl 2 , 10 dextrose, 25 NaHCO 3 , and oxygenated with 95% O 2 -5%CO 2 . Horizontal brain slices (250 µm) containing VTA were incubated for 30 min at 35°C in a chamber filled with artificial cerebrospinal fluid (aCSF) and stored at room temperature for the remainder of the day. Slices were transferred to a recording chamber where they continuously received aCSF (33-35°C) at a rate of 2 ml per minute by a gravity-feed system. aCSF was composed of (in mM): 126 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 2 MgCl 2 , 2 CaCl 2 , 10 dextrose, 25 NaHCO 3 , was equilibrated using 95% O 2 -5%CO 2 and had a pH of 7.2.
Midbrain neurons were visualized using gradient contrast illumination through a 40X water-immersion lens attached to an Olympus BX51 upright microscope. Neurons were considered dopaminergic based on the following electrophysiological criteria: have a hyperpolarization-activated inward current, slow spontaneous firing frequency ≤5 Hz and an action potential half-width ≥1.5 ms. Dopamine (THpositive) neurons filled with biocytin were further identified immunocytochemically.
Whole cell recording pipettes with a tip resistance between 4 and 6 MOhm were pulled from borosilicate glass using a P-97 Flaming/Brown electrode puller (Sutter Instruments) and filled with internal solution containing (in mm): 110 D-gluconic acid, 110 CsOH, 10 CsCl 2 , 1 EGTA, 10 HEPES, 1 ATP, 10 mm phosphocreatine.
Postsynaptic currents (PSC) were evoked by placing a 250 µm bipolar stimulating electrode within 500 µm of the neuron being recorded and applying a single pulse (0.05 ms). Whole cell recordings were made using a Multiclamp 700B amplifier (Molecular Devices). Experiments were conducted in the presence of the AMPA receptor antagonist, NBQX (25 µM), to isolate NMDA receptor-mediated currents. Signals were digitized at 50 kHz and saved to a hard drive for analysis using Axograph X (Axograph). Access resistance was monitored and measured post hoc to ensure access resistance had not changed by < 20%.
Statistics: A student's two-tailed t-test was used when comparing between two groups. A P-value < 0.05 was used as our significance level for all tests.
Chemical Synthesis
tert-Butyldimethylsilyl chloride (9.05 g, 60 mmol, 3 eq) and Imidazole (6.81 g, 100 mmol, 5 eq) were added to a solution of Dehydroepiandrosterone (DHEA) (6.00 g, 20 mmol, 1 eq) in acetonitrile (100 ml). The reaction was stirred at room temperature for 6 h. The reaction mixture was diluted with water (50 ml) and extracted three times with ethyl acetate (3 × 50 ml). The organic layer was concentrated under reduced pressure to afford DHEA-3β-tert-butyldimethylsilyl ether (5) 
To a solution of DHEA-3β-tert-butyldimethylsilyl ether 5 (3.00 g, 7.5 mmol, 1 eq) in toluene (100 ml) was added 2-aminomethyl pyridine (2.20 g, 23 mmol, 3 eq) and (50 mg, 0.2 mmol, 0.03 eq) of para-toluenesulfonic acid. The solution was refluxed for 4 h with a Dean Stark apparatus. The progress of the reaction was monitored by 1 H NMR. The reaction was cooled to room temperature. The reaction mixture was diluted with ethyl acetate and subsequently washed three times with saturated NaHCO 3 (200 ml), dried with MgSO 4 and concentrated under reduced pressure to afford the imine 6 as a white solid (3.1904 98 mmol, 2 eq) were added to the imine 6 (2.12 g, 4.4 mmol, 1 eq) in an oven baked round bottom flask backfilled with N 2 gas. Acetone (18 ml) and methanol (18 ml) were added to the mixture and stirred for 10 min. The reaction solution turned brown after stirring for 5 min. The round bottom flask containing the reaction mixture was sealed with a rubber stopper and degassed. The reaction solution was bubbled with O 2 gas with the aid of a balloon and an exit needle until the color of the solution changed from brown to green. The reaction mixture was heated at 50°C under an atmosphere of O 2 for 2 h. The reaction was cooled to room temperature and then quenched by adding saturated Na 4 EDTA (30 ml, pH = 5) and ethyl acetate (15 ml). The resulting solution was stirred for 1 h and then transferred to a separatory funnel and allowed to stand for 5 min to differentiate the organic layer from the aqueous layer. The organic layer was separated from the aqueous layer. The aqueous layer was extracted with ethyl acetate (3 × 50 ml). The combined organic layers were concentrated under reduced pressure to afford a crude brown oil. The crude brown oil was purified by flash column chromatography (100% hexanes to 50% ethyl acetate in hexanes) to afford the alcohol 7 as a white solid (0.9 g, 2.1 mmol, 48% 
17-,17-Ethylenedioxy
Ethylene glycol (2 ml, 35.9 mmol, 16 mol eq), para-toluenesulfonic acid (0.103 g, 0.59 mmol, 0.28 eq) were added to the ketone 7 (0.89 g, 2.13 mmol, 1 eq) in toluene (100 ml). The reaction was refluxed with a Dean Stark apparatus for 4 h. Upon completion of the reaction as judged by TLC, the reaction was cooled to room temperature. The reaction mixture was diluted with ethyl acetate (150 ml), washed three times with saturated aqueous NaHCO 3 (3 × 100 ml) and dried with magnesium sulfate. The resulting solution was concentrated under reduced pressure to form a crude yellowish-brown oil, which was the purified by silica gel column chromatography (100% hexanes to 50% ethyl acetate in hexanes) to afford the ketal 8 as a white solid (0.2064 g, 0.44 mmol, 20%); mp: 140-143°C; R f : 0. 15 19 mmol, 1 eq) was added to a solution of the ketal-alcohol 8 (0.90 g, 19 mmol, 1 eq) in dichloromethane (50 ml). The solution was stirred at room temperature for 6 h. The reaction mixture was washed with 5% NaOH (3 × 50 ml) and then concentrated under reduced pressure to obtain a crude yellow solid residue. The crude residue was purified by silica gel column chromatography (100% hexanes to 10% ethyl acetate in hexanes) to afford ketone 9 as a white solid (0.419 g, 0.909 mmol, 48%). An analytical sample of compound 9 was recrystallized from 100% acetone to afford colorless needlelike crystals: mp 143-145°C; R f : 0. 6 .0 mmol, 1.8 eq), was added to ketone 9 (1.5 g, 3.3 mmol, 1.0 eq) in THF (50 ml, dried under molecular sieves) at −78°C under an atmosphere of N 2 . The reaction was stirred for 12 h and then quenched with the addition of water (20 ml) dropwise at −78°C, allowed to warm to room temperature. The reaction mixture was extracted with ethyl acetate (3 × 50 ml). The organic layer was concentrated under reduced pressure and purified by silica gel column chromatography to afford the 12α-hydroxylated compound (10) 8 .0 mmol, 37 mol eq) was added to a solution of ketal 10 (100 mg, 0.22 mmol, 1.0 eq) in THF (10 ml). The reaction was stirred for 4 h and quenched with saturated NaHCO 3 (aqueous) and extracted with CH 2 Cl 2 (50 ml). The CH 2 Cl 2 extract was concentrated under reduced pressure and purified by silica gel column chromatography (70% hexanes to 50% hexanes in ethyl acetate) to afford the diol 1 as a white solid (45 mg, 0.15 mmol, 68% 3β-,12α-Diacetoxy-androst-5-en-17-one (Compound 11): Acetic anhydride (10.0 ml, 106 mmol, 17.9 eq) and pyridine (1.20 ml, 14.8 mmol, 2.5 eq) were added to diol 1 (1.8 g, 5.9 mmol, 1 eq) . The reaction was stirred at room temperature for 12 h. The reaction mixture was diluted with 50 ml of water and extracted with ethyl acetate (3 × 50 ml). The organic layer was concentrated under reduced pressure and purified by silica gel chromatography (90% hexanes to 70% hexanes in ethyl acetate) to afford diacetate 11 as a white solid ( 96 (m, 2H), 1.98-1.94 (s, 3H), 1.90-1.80 (m, 2H),  1.79-1.50 (m, 6H), 1.33-1.18 (m, 1H) 35 mmol, 6 eq) was added to the reaction and stirred for another 20 min. Diacetate 11 (0.600 g, 2.059 mmol, 1 eq) in CH 2 Cl 2 (10 ml) was added to the reaction mixture and stirred for 24 h. The mixture was concentrated under reduced pressure to obtain a crude black mixture which was bounded to silica gel and introduced onto an already packed silica gel column and purified (80% hexanes to 50% hexanes in ethyl acetate) to afford diketone 12 as a white solid (0.370 g, 0.919 mmol, 45% 3β-,12α-Dihydroxy-andros-5-en-7,17-dione (Compound 2): To a stirring solution of diketone 12 (0.35 g, 0.87 mmol, 1 eq) in methanol (30 ml) was added potassium carbonate (120 mg, 0.87 mmol, 1 eq). The reaction was stirred at room temperature for 24 h. The resulting solution was diluted with water (30 ml) and extracted with ethyl acetate (100 ml). The ethyl acetate extract was concentrated under reduced pressure and then purified by silica gel column chromatography (50% hexanes to 100% ethyl acetate) to afford 12α-hydroxy-7-oxo DHEA (2) .51 mmol, 6 eq) was added to a stirring solution of CH 2 Cl 2 (50 ml) in a round bottom flask at −78°C and left to stir for 15 min. 3,5-Dimethylpyrazole (0.63 g, 6.51 mmol, 6 eq) was added to the reaction and was stirred for 25 min. Ketone 9 (0.50 g, 1.09 mmol, 1 eq) was dissolved in CH 2 Cl 2 (10 ml) and added to the reaction mixture and stirred for 12 h. In a separate round bottom flask A, a stirring solution of CH 2 Cl 2 (50 ml) was cooled to −78°C and chromium trioxide (0.69 g, 6.51 mmol, 6 eq) and 3,5-dimethylpyrazole (0.63 g, 6.51 mmol, 6 eq) were added sequentially at a 15 min-interval. After 1 h, the existing reaction was transferred to reaction flask A at −78°C and stirred for another 12 h. A crude black solution was obtained, bound to silica gel and loaded onto an already packed column and purified (hexane 100% to 80% hexanes in ethyl acetate) to afford diketone 13 as a pale-yellow solid (0.46 g, 0.97 mmol, 89%). An analytical sample of compound 13 was recrystallized from hexanes/ethyl acetate (1:1) , 475.2874; found, 475.2874 (Δ 0.07 ppm). *In subsequent procedures to oxidize the C7-allylic position using CrO 3 and 3,5-dimethylpyrazole, we found that increasing the mol equivalents of both CrO 3 and 3,5-dimethylpyrazole to 12 mol equivalents resulted in higher yields to afford the C7-keto steroid product.
17,17-Ethylenedioxy
: L-Selectride (15 ml of 1.0 M solution in THF, 15 mmol, 16 eq) was added to a solution of diketone 13 (0.4613 g, 0.9717 mmol, 1 eq) in THF (30 ml) dropwise at −78°C under an atmosphere of N 2 . The reaction was stirred for 12 h and then quenched by adding water (20 ml) to reaction solution at 78°C. The mixture was warmed to room temperature and then extracted with ethyl acetate (3 × 50 ml). The ethyl acetate extract was concentrated under reduced pressure and purified by silica gel column chromatography (silica gel, 100% hexanes to 50% hexanes in ethyl acetate) to afford diol 14 as a white solid (0.20 g, 0.42 mmol, 42% 70 mmol, 1 eq) in acetic anhydride (15 ml, 157 mmol, 58 eq) was added pyridine (1.00 ml, 12.4 mmol, 4.59 eq). The reaction was stirred at room temperature for 24 h. The reaction mixture was diluted with water (50 ml) and extracted with ethyl acetate (3 × 50 ml). The ethyl acetate layer was concentrated under reduced pressure to produce a crude brown oil which was further purified by silica gel column chromatography (100% hexanes to 80% hexanes in ethyl acetate) to afford acetate 15 as a yellow oil (0. 5 g, 2. 89 mmol, 1 eq) in methanol (50 ml) at 0°C was added sodium borohydride powder (4.00 g, 105 mmol, 36 eq). The reaction was stirred at 0°C and gradually warmed to room temperature over 6 h. The solution was diluted with water (50 ml) and transferred to a separatory funnel, which was extracted with ethyl acetate (3 × 50 ml). The ethyl acetate layer was concentrated under reduced pressure to form crude white solid which was purified by silica gel column chromatography (100% hexanes to 70% ethyl acetate) to afford an epimeric mixture of 7α-and 7β-hydroxy products as a colorless solid (1.2 g, 2.3 mmol, 80%), which were unresolvable from TLC analysis. Based on the integration of the Δ 5 -proton in the 1 H NMR spectrum, the mixture of the 7α-hydroxy and 7β-hydroxy products were in a 1:4 ratio. This ratio was determined by integrating the Δ 5 -protons of the 7α-hydroxy epimer and the 7β-hydroxy epimer (17) in the 1 H NMR spectrum, which appeared at δ 5.56 ppm and 5.21 ppm, respectively. The upfield chemical shift (δ 5.21 ppm) was assigned as the 7β-hydroxy epimer as we have done in a previous study [16] 
To the 7α*/7β-epimeric mixture of alcohol 17 (vide supra) (1.2 g, 2.3 mmol, 1 eq) in acetonitrile (50 ml) was added tert-butyldimethylsilyl chloride (3.11 g, 20.6 mmol, 9 eq) and imidazole (2.5 g, 36 mmol, 15 eq). The reaction was refluxed at 90°C for 12 h. The reaction was diluted with water (50 ml) and extracted with ethyl acetate (3 × 50 ml). The organic layer was concentrated under reduced pressure and purified by silica gel column chromatography (hexanes 90% to 80% hexanes in ethyl acetate) to afford the TBDMS ether 18 as a white solid (0. 23 (m, 2H), 1.20-1.13 (td, J = 11, 5 Hz, 1H), 0.97 (s, 3H) 1.17 ppm) . *The minor 7α-OTBDMS epimer product was observed through 1 H NMR spectroscopy (δ 5.45 (d, J = 6 Hz, 1H), which corresponds to the Δ 5 proton), however over the sequence of the next four synthetic steps toward 7β-,12α-dihydroxy-DHEA (Compound 4), the amount of the 7α-hydroxy epimer decreases relative to the 7β-hydroxy epimer. Since the 7α/7β epimeric mixture was resolvable by TLC, an analytical sample of the TBDMS ether 18 was purified by column chromatography (isocratic 20% ethyl acetate in hexane). The isolated products were collected across 20 test-tubes (2 ml each) and then each tube was dried down using a stream of nitrogen. 41 mmol, 1 eq) in methanol (50 ml). The reaction was refluxed at 60°C for 6 h. The solution was cooled to room temperature and diluted with water (50 ml) and extracted with ethyl acetate (3 × 50 ml). The ethyl acetate extract was concentrated under reduced pressure and purified by silica gel column chromatography (hexanes 100% to 20% ethyl acetate in hexanes) to afford the 12β alcohol 19 as a white solid (0.643 g, 1 
